Resistance to imatinib in patients with chronic myelogenous leukemia and the splice variant BCR-ABL1 35INS-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Resistance to imatinib in patients with chronic myelogenous leukemia and the splice variant BCR-ABL1 35INS

Published:2016-10 Issue: Volume:49 Page:108-112
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Berman Ellin,Jhanwar Suresh,Hedvat Cyrus,Arcila Maria E.,Wahab Omar Abdel-,Levine Ross,Maloy Molly,Ma Wanlong,Albitar Maher

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference32 articles.

1. A minute chromosome in human chronic granulocytic leukemia;Nowell;Science,1960

2. A new consistent abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining;Rowley;Nature,1973

3. An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity;Konopka;Cell,1984

4. Structural organization of the bcr gene and its role in the Ph’ translocation;Heisterkamp;Nature,1985

5. Fused transcript of abl and bcr genes in chronic myelogenous leukemia;Shtivelman;Nature,1985

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BCR::ABL1 Proteolysis-targeting chimeras (PROTACs): The new frontier in the treatment of Ph+ leukemias?;Leukemia;2024-08-04

2. Biological relevance of alternative splicing in hematologic malignancies;Molecular Medicine;2024-05-17

3. Spirooxadiazoline‐oxindoles derived from imatinib show antimyeloproliferative potential in K562 cells;Archiv der Pharmazie;2024-04-16

4. Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2024-02

5. A CML Patient Carrying <i>BCR::ABL1</i> Splicing Variants Did not Experience Blast Crisis for 15 Years without Responding to Various TKIs;Internal Medicine;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3